https://breast-cancer-research.biomedcentral....21-01391-1

Conclusions
The safety profile of leronlimab, together with strong preclinical evidence to both prevent and reduce established breast cancer metastasis herein, suggests studies of clinical efficacy may be warranted.

Geez, ya think??